{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:08:59Z","timestamp":1792382939359,"version":"4.4.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T00:00:00Z","timestamp":1527206400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1093\/ndt\/gfy129","type":"journal-article","created":{"date-parts":[[2018,4,23]],"date-time":"2018-04-23T19:09:13Z","timestamp":1524510553000},"page":"408-414","source":"Crossref","is-referenced-by-count":69,"title":["Sclerostin in chronic kidney disease\u2013mineral bone disorder think first before you block it!"],"prefix":"10.1093","volume":"34","author":[{"given":"Vincent M","family":"Brandenburg","sequence":"first","affiliation":[{"name":"Department of Cardiology, University Hospital of the RWTH Aachen, Aachen, Germany"},{"name":"Department of Cardiology, Rhein-Maas Klinikum, W\u00fcrselen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Verhulst","sequence":"additional","affiliation":[{"name":"Laboratory of Pathophysiology, Department of Biomedical Sciences, University of Antwerp, Wilrijk, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Babler","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital of the RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C","family":"D'Haese","sequence":"additional","affiliation":[{"name":"Laboratory of Pathophysiology, Department of Biomedical Sciences, University of Antwerp, Wilrijk, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Evenepoel","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, Laboratory of Nephrology, KU Leuven and University Hospitals Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Kaesler","sequence":"additional","affiliation":[{"name":"Department of Nephrology, University Hospital of the RWTH Aachen, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1098\/rstb.2007.2251","article-title":"From individual Wnt pathways towards a Wnt signalling network","volume":"363","author":"Kestler","year":"2008","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1042\/BJ20121284","article-title":"Wnt\/beta-catenin signalling: from plasma membrane to nucleus","volume":"450","author":"Kim","year":"2013","journal-title":"Biochem J"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00467-015-3069-7","article-title":"From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD","volume":"31","author":"Brandenburg","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2011.10.044","article-title":"Update on Wnt signaling in bone cell biology and bone disease","volume":"492","author":"Monroe","year":"2012","journal-title":"Gene"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1210\/er.2011-1060","article-title":"Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases","volume":"33","author":"Ke","year":"2012","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(14)70059-2","article-title":"Bone: a new endocrine organ at the heart of chronic kidney disease and mineral and bone disorders","volume":"2","author":"Vervloet","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B7","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B8","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.15190\/d.2016.2","article-title":"Validation of commercially available ELISAs for the detection of circulating sclerostin in hemodialysis patients","volume":"4","author":"Mause","year":"2016","journal-title":"Discoveries (Craiova)"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B9","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B10","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B11","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1359\/jbmr.090730","article-title":"Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice","volume":"25","author":"Kramer","year":"2010","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B13","first-page":"139","article-title":"Identification of the disease-causing gene in sclerosteosis\u2013discovery of a novel bone anabolic target?","volume":"4","author":"Balemans","year":"2004","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bone.2016.10.010","article-title":"Sclerostin deficiency in humans","volume":"96","author":"van Lierop","year":"2017","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/jbmr.2461","article-title":"The anti-osteoanabolic function of sclerostin is blunted in mice carrying a high bone mass mutation of Lrp5","volume":"30","author":"Yorgan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B16","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jbmr.14","article-title":"Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength","volume":"25","author":"Ominsky","year":"2010","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bone.2015.08.007","article-title":"Differential temporal effects of sclerostin antibody and parathyroid hormone on cancellous and cortical bone and quantitative differences in effects on the osteoblast lineage in young intact rats","volume":"81","author":"Ominsky","year":"2015","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B18","doi-asserted-by":"crossref","first-page":"15632","DOI":"10.1038\/srep15632","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength of intact bones in adult male rats","volume":"5","author":"Suen","year":"2015","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B20","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","article-title":"The relation between renal function and serum sclerostin in adult patients with CKD","volume":"8","author":"Pelletier","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/ndt\/gfu301","article-title":"High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study","volume":"30","author":"Drechsler","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B23","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/ndt\/gfx282","article-title":"Sclerostin and chronic kidney disease: the assay impacts what we (thought to) know","volume":"33","author":"Delanaye","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B24","first-page":"1217","article-title":"Serum sclerostin: relation with mortality and impact of hemodiafiltration","volume":"32","author":"Lips","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B25","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s11255-018-1795-z","article-title":"Elevated levels of serum sclerostin are linked to adverse cardiovascular outcomes in peritoneal dialysis patients","volume":"50","author":"Gong","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s40620-017-0397-7","article-title":"Adynamic bone disease is a predominant bone pattern in early stages of chronic kidney disease","volume":"30","author":"Massy","year":"2017","journal-title":"J Nephrol"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B27","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B28","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.kint.2016.06.019","article-title":"Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease","volume":"90","author":"Cejka","year":"2016","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2017.11.015","article-title":"Sclerostin deficiency modifies the development of CKD-MBD in mice","volume":"107","author":"Kaesler","year":"2018","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B31","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.kint.2016.12.029","article-title":"The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease","volume":"91","author":"Graciolli","year":"2017","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","article-title":"Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease","volume":"90","author":"Carrillo-Lopez","year":"2016","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.kint.2017.02.014","article-title":"Klotho expression in osteocytes regulates bone metabolism and controls bone formation","volume":"92","author":"Komaba","year":"2017","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B34","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bone.2012.09.016","article-title":"Effects of PTH on osteocyte function","volume":"54","author":"Bellido","year":"2013","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","volume":"37","author":"Keller","year":"2005","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B36","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1073\/pnas.1221255110","article-title":"Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of calcium","volume":"110","author":"Ryan","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5301\/jn.5000212","article-title":"Osteoporosis and adynamic bone in chronic kidney disease","volume":"26","author":"Cannata","year":"2013","journal-title":"J Nephrol"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2015.04.021","article-title":"Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions","volume":"77","author":"Newman","year":"2015","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B39","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/jbmr.2372","article-title":"Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy","volume":"30","author":"Moe","year":"2015","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B40","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tem.2012.06.001","article-title":"Wnt signaling in cardiovascular physiology","volume":"23","author":"Marinou","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B41","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1136370","article-title":"LRP6 mutation in a family with early coronary disease and metabolic risk factors","volume":"315","author":"Mani","year":"2007","journal-title":"Science"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B42","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bone.2017.01.023","article-title":"The chronic kidney disease - Mineral bone disorder (CKD-MBD): advances in pathophysiology","volume":"100","author":"Hruska","year":"2017","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B43","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1681\/ASN.2013080818","article-title":"CKD-induced wingless\/integration 1 inhibitors and phosphorus cause the CKD-mineral and bone disorder","volume":"25","author":"Fang","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B44","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1056\/NEJMc1402396","article-title":"Romosozumab in postmenopausal women with osteopenia","volume":"370","author":"Evenepoel","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"J Med Genet"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B46","first-page":"648","article-title":"Warfarin: to use or not to use in chronic kidney disease patients?","volume":"23","author":"Cozzolino","year":"2010","journal-title":"J Nephrol"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B47","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1161\/ATVBAHA.113.302244","article-title":"Warfarin induces cardiovascular damage in mice","volume":"33","author":"Kruger","year":"2013","journal-title":"Arter Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/ATVBAHA.111.237834","article-title":"Transglutaminase 2-mediated activation of beta-catenin signaling has a critical role in warfarin-induced vascular calcification","volume":"32","author":"Beazley","year":"2012","journal-title":"Arter Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/ATVBAHA.116.308723","article-title":"Wnt signaling pathway inhibitor sclerostin inhibits Angiotensin II-induced aortic aneurysm and atherosclerosis","volume":"37","author":"Krishna","year":"2017","journal-title":"Arter Thromb Vasc Biol"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B50","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2369-14-219","article-title":"Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study","volume":"14","author":"Brandenburg","year":"2013","journal-title":"BMC Nephrol"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B51","doi-asserted-by":"crossref","first-page":"e19595","DOI":"10.1371\/journal.pone.0019595","article-title":"The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B52","first-page":"317","article-title":"Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study","volume":"22","author":"Koos","year":"2013","journal-title":"J Heart Valve Dis"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B53","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/ndt\/gfs466","article-title":"Novel insights into osteogenesis and matrix remodelling associated with calcific uraemic arteriolopathy","volume":"28","author":"Kramann","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B54","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/ki.2015.194","article-title":"Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification","volume":"88","author":"Qureshi","year":"2015","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t2019030502560054600_gfy129-B55","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ki.2014.349","article-title":"Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism","volume":"87","author":"Behets","year":"2015","journal-title":"Kidney Int"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/34\/3\/408\/27989154\/gfy129.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T07:56:26Z","timestamp":1551772586000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/34\/3\/408\/5004424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,5,24]]},"published-print":{"date-parts":[[2019,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfy129","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3]]},"published":{"date-parts":[[2018,5,24]]}}}